General Genomics Inc.

General Genomics Inc. is a United States-based startup that prides itself on "Helping heal the world through better information and objective data science." Established in 2020, the company has garnered attention through its innovative approach. With a slogan that emphasizes "DNA = the cure," General Genomics is dedicated to leveraging software and apps to empower individuals with actionable insights into their health. The startup has recently secured a $900.00K Seed Round investment on 10th December 2020, indicative of investor confidence in their vision. General Genomics Inc. positions itself as a pioneer in the field of genetics and health. Its technology is designed to amalgamate personal health information, family history, and genetics, subsequently analyzing these data points against thousands of variables while prioritizing data privacy. The outcome is comprehensive knowledge that aims to enable individuals to take control of their well-being. By uncovering unknown health aspects, General Genomics aspires to facilitate a return to a normal way of life. With a focus on empowering individuals and families to make informed health decisions, the company is committed to promoting proactive wellness practices. The Seed Round investment signifies industry validation and economic support for their mission. General Genomics Inc. reflects a promising venture at the forefront of healthcare technology, poised to revolutionize the way individuals engage with and manage their health.